Han J Y, Zhao Y, Anderson W F, Cannon P M
Gene Therapy Laboratories, Norris Cancer Center and Department of Biochemistry and Molecular Biology, University of Southern California School of Medicine, Los Angeles, California 90033, USA.
J Virol. 1998 Nov;72(11):9101-8. doi: 10.1128/JVI.72.11.9101-9108.1998.
For the amphotropic murine leukemia virus (MuLV), a 208-amino-acid amino-terminal fragment of the surface unit (SU) of the envelope glycoprotein is sufficient to bind to its receptor, Pit2. Within this binding domain, two hypervariable regions, VRA and VRB, have been proposed to be important for receptor recognition. In order to specifically locate residues that are important for the interaction with Pit2, we generated a number of site-specific mutations in both VRA and VRB and analyzed the resulting envelope proteins when expressed on retroviral vectors. Concurrently, we substituted portions of the amphotropic SU with homologous regions from the polytropic MuLV envelope protein. The amphotropic SU was unaffected by most of the point mutations we introduced. In addition, the deletion of eight residues in a region of VRA that was previously suggested to be essential for Pit2 utilization only decreased titer on NIH 3T3 cells by 1 order of magnitude. Although the replacement of the amino-terminal two-thirds of VRA with the polytropic sequence abolished receptor binding, smaller nonoverlapping substitutions did not affect the function of the protein. We were not able to identify a single critical receptor contact point within VRA, and we suggest that the amphotropic receptor binding domain probably makes multiple contacts with the receptor and that the loss of some of these contacts can be tolerated.
对于双嗜性鼠白血病病毒(MuLV),包膜糖蛋白表面单位(SU)的一个208个氨基酸的氨基末端片段足以与它的受体Pit2结合。在这个结合结构域内,两个高变区VRA和VRB被认为对受体识别很重要。为了特异性定位与Pit2相互作用重要的残基,我们在VRA和VRB中产生了许多位点特异性突变,并分析了在逆转录病毒载体上表达时产生的包膜蛋白。同时,我们用多嗜性MuLV包膜蛋白的同源区域替换了双嗜性SU的部分区域。双嗜性SU不受我们引入的大多数点突变的影响。此外,在先前认为对利用Pit2至关重要的VRA区域缺失八个残基,仅使在NIH 3T3细胞上的滴度降低了1个数量级。虽然用多嗜性序列替换VRA的氨基末端三分之二消除了受体结合,但较小的不重叠替换并不影响该蛋白的功能。我们无法在VRA内确定单个关键的受体接触点,我们认为双嗜性受体结合结构域可能与受体进行多次接触,并且其中一些接触的丧失是可以容忍的。